LCN2 and acute kidney injury: Additional studies are needed to delineate between CHI3L1 as a marker of inflammation versus AKI by comparing CHI3L1 levels to other established biomarkers of kidney injury (e.g. NGAL) that are well characterized in association with changes to kidney function.